Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Gene Therapy00:59

Gene Therapy

25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse.

Cell·2026
Same author

Comparative Outcomes of Doxorubicin and Cyclophosphamide with Sequential versus Concurrent Paclitaxel in the Adjuvant Treatment of Non-Metastatic Breast Cancer: A Cross-Sectional Analytical Study.

JNMA; journal of the Nepal Medical Association·2026
Same author

WBC Growth Factors: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Lung health in the Terai region of Nepal.

Chronic respiratory disease·2026
Same author

Availability, Affordability, and Variations in Price of GI Cancer Medicines in Nepal.

JCO global oncology·2025
Same author

Comparison of the effectiveness of oral morphine versus oral tramadol on early pain control in opioid-naive patients with moderate cancer pain.

Ecancermedicalscience·2025

相关实验视频

Updated: Jun 13, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

发展中国家的CAR-T细胞疗法:我们应该等待多久?

Sanjivan Gautam1, Balram Gautam2,3, Ramila Shilpakar2,4

  • 1Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA Om.kurmi@coventry.ac.uk sanjivan@outlook.com.

Journal for immunotherapy of cancer
|January 11, 2025
PubMed
概括

尼泊尔正在开发化学抗原受体 (CAR) T细胞疗法,以提高低收入和中等收入国家 (LMICs) 的癌症存活率. 该倡议旨在克服获取障碍,并降低先进癌症治疗的成本.

关键词:
化学抗原受体 - - CAR

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

470

相关实验视频

Last Updated: Jun 13, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.2K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

470

科学领域:

  • 在瘤学瘤学.
  • 免疫治疗是一种免疫疗法.
  • 再生医学是一种再生医学.

背景情况:

  • 与高收入国家相比,低收入和中等收入国家 (LMICs) 的癌症负担更高,生存率更低.
  • 对于先进的治疗方法 (如化学抗原受体 (CAR) T细胞疗法) 的有限获取有助于癌症护理的差异.
  • 尼泊尔在为其人口提供先进的癌症疗法方面面临着挑战.

研究的目的:

  • 评估在尼泊尔建立CAR T细胞疗法的可行性,这是一个低收入国家.
  • 探索当地制造能力和用于CAR T细胞治疗的试剂采购.
  • 为了降低LMIC癌症患者CAR T细胞治疗的成本.

主要方法:

  • 对当地实验室生产CAR T细胞的能力进行研究.
  • 从当地或发达国家采购试剂.
  • 建立一个良好的制造实践 (GMP) 级的CAR T细胞制造设施.

主要成果:

  • 成功的研究证明了当地CAR T细胞生产的可行性.
  • 启动用于临床试验的GMP级制造设施.
  • 确定在LMICs建立先进疗法的技术,监管和资源挑战.

结论:

  • 尼泊尔的当地倡议正在努力使CAR T细胞疗法更容易获得和负担得起.
  • 尼泊尔的经验为其他发展中国家提供了宝贵的见解,旨在实施先进的癌症治疗方法.
  • 跨学科合作和全球支持对于实现公平获得尖端医疗干预措施至关重要.